Human Tumor-Infiltrating Dendritic Cells: From in Situ Visualization to High-Dimensional Analyses

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Tumor-immune interactions are dynamic.
• Dendritic cells (DCs) are key activators of anti-tumor T cell responses.
• Accurate identification of diverse DC subsets within tumors is crucial for understanding anti-tumor immunity.

Purpose of the Study:

• To review the evolution of methods for identifying tumor-associated dendritic cells (DCs).
• To highlight the role of high-dimensional technologies in DC characterization.
• To focus on the prognostic significance of DCs in cancer.

Main Methods:

• Review of literature on DC identification techniques.
• Discussion of traditional methods like immunostaining and flow cytometry.
• Emphasis on advanced technologies such as mass cytometry and single-cell transcriptome sequencing.

Main Results:

• Early studies used limited markers for in situ DC identification.
• Flow cytometry enabled multi-marker characterization of tumor-associated DCs.
• High-dimensional technologies have refined DC classification and revealed novel populations.

Conclusions:

• Technological advancements have standardized DC classification across studies.
• Understanding DC subsets is essential for deciphering their role in anti-tumor immunity.
• The prognostic impact of DCs in cancer is an area of growing clinical importance.